Home ›
Trademark Categories ›
Pharmaceuticals ›
2009 ›
EQ ›
EQUIDACENT
Trademark search for:
EQUIDACENT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-09-26 — Application filed
2018-09-29 — Application filed
2018-10-03 — Application filed
2019-01-08 — Assigned to examiner
2019-01-10 — Final disposition recorded
2019-01-10 — Final disposition recorded
2019-01-10 — Final disposition recorded
2019-06-06 — Office action issued
2019-06-11 — Assigned to lie
2019-06-13 — Correspondence received in law office
2019-06-13 — Teas/email correspondence entered
2019-06-14 — Approved for pub - principal register
2019-07-03 — Notification of notice of publication e-mailed
2019-07-23 — Published for opposition
2019-07-23 — Official gazette publication confirmation e-mailed
2019-08-08 — Teas revoke/app/change addr of atty/dom rep received
2019-08-08 — Attorney/dom.rep.revoked and/or appointed
2019-09-17 — Noa e-mailed - sou required from applicant
2020-02-10 — Sou teas extension received
2020-02-10 — Sou extension 1 filed
2020-02-10 — Sou extension 1 granted
2020-02-12 — Notice of approval of extension request e-mailed
2020-09-07 — Sou teas extension received
2020-09-07 — Sou extension 2 filed
2020-09-07 — Sou extension 2 granted
2020-09-09 — Notice of approval of extension request e-mailed
2020-12-09 — Automatic update of assignment of ownership
2021-03-04 — Sou teas extension received
2021-03-04 — Sou extension 3 filed
2021-03-17 — Case assigned to intent to use paralegal
2021-03-18 — Sou extension 3 granted
2021-03-19 — Notice of approval of extension request e-mailed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of correspondence received
2021-10-18 — Application abandoned
2021-10-18 — Application abandoned
2021-10-18 — Final status recorded
Owner Information
CENTUS BIOTHERAPEUTICS LIMITED
CAMBRIDGE GB
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP 1800 Concord Pike, A2C Wilmington, DE 19850-5437 UNITED STATES
Filing Details
Filing Date:
2018-09-26
Status Date:
2021-10-18
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.